• VER 155008: HSP 70 Inhibitor Workflows

  2026-08-30

  Build a connected workflow from Hsp70 ATPase biochemistry to apoptosis and cancer cell proliferation inhibition with VER 155008. The approach also uses a TGEV HSC70 study to sharpen assay design while clearly separating mechanistic insight from unvalidated antiviral claims.

• Proteinase K for DNA and EV Protein Workflows

  2026-08-29

  Proteinase K combines broad protein digestion with compatibility across detergents, EDTA, and moderate heat, making it a practical choice for genomic DNA purification and nuclease cleanup. Its value also extends to carefully controlled extracellular-vesicle assays, where proteolysis can distinguish surface-associated from protected protein cargo.

• H-89 for PKA and cAMP Signaling Workflows

  2026-08-29

  Use H-89 as a time-resolved probe to test whether PKA connects Wnt stimulation with O-GlcNAcylation, glycolytic remodeling, and osteoblast differentiation. This workflow emphasizes concentration controls, acute-versus-chronic treatment windows, and orthogonal validation rather than treating H-89 as definitive genetic proof.

• (+)-Bicuculline: Practical Lab Workflow

  2026-08-28

  This guide explains how to prepare, apply, and quality-control (+)-Bicuculline as a GABAA receptor antagonist for controlled neuroscience experiments involving inhibitory synaptic transmission and related signaling readouts. It is intended for scientific research only and should not be used for diagnosis, treatment, or clinical decision-making.

• Phytol Workflows for RXR Assays and Design

  2026-08-28

  Build more interpretable Phytol experiments by separating RXR activation from solvent, isomer, metabolism, and GABAergic confounders. A polymer self-assembly study adds a practical screening principle: vary composition and observation time systematically instead of assuming one formulation or readout will be optimal.

• AP-2α–MGMT Control in Recurrent Glioblastoma

  2026-08-27

  The reference study identifies AP-2α as a direct transcriptional suppressor of MGMT in recurrent glioblastoma, linking loss of AP-2α to temozolomide resistance and reduced DNA damage. Its combination of promoter assays, resistant glioma models, DNA-damage measurements, and intracranial experiments provides a mechanistic framework for restoring alkylating-agent sensitivity, while also indicating important limits for translating expression changes into functional MGMT inhibition.

• Hematoxylin and Eosin Staining Kit Guide

  2026-08-27

  The Hematoxylin and Eosin Staining Kit (SKU K1142) provides ready-to-use reagents for visualizing nuclei, cytoplasm, extracellular matrix, and overall tissue architecture in paraffin, frozen, and cytological preparations. It is intended for controlled scientific research workflows, not clinical diagnosis or medical use.

• FGFR3 Inhibition in SLC26A2 Chondrodysplasia

  2026-08-26

  The reference study combines genetic models and pharmacological inhibition to show that excessive FGFR3 signaling contributes to SLC26A2-related chondrodysplasia in mice. Its findings support FGFR3 pathway modulation as a potential treatment strategy while highlighting the importance of developmental timing, genetic context, and validation beyond animal models.

• Cy3 NHS ester (non-sulfonated): Practical Guide

  2026-08-26

  Cy3 NHS ester (non-sulfonated) provides an orange fluorescent handle for labeling primary amino groups on proteins, peptides, and amine-modified oligonucleotides. It is suitable when a DMSO- or DMF-containing workflow is acceptable, but it is not the first choice for delicate aqueous proteins that require a water-soluble sulfonated dye.

• Everolimus (RAD001): Measure More Than Viability

  2026-08-25

  Everolimus (RAD001) is an mTOR pathway inhibitor whose effects on growth arrest and cell death should be measured separately. This guide combines its FKBP12–mTOR mechanism with a response-resolved assay strategy grounded in cancer pharmacology research.

• PARP1/FAK/COL5A1 Signaling in Ovarian Cancer

  2026-08-25

  The reference study establishes a cholesterol-resistant ovarian cancer model and identifies a PARP1/FAK/COL5A1 axis that promotes epithelial–mesenchymal transition and tumorigenesis. Its long-term adaptation design, mechanistic perturbation experiments, tissue analysis, and in vivo validation provide a framework for studying cholesterol-linked progression and FAK signaling pathway dependence.

• Pentoxifylline and Preterm Monocyte Hyperinflammation

  2026-08-24

  The reference study shows that pentoxifylline suppresses LPS-driven inflammatory activation in monocytes from preterm and term infants, with particularly strong effects on CD14, CD11b, and TLR4-related responses in preterm samples. Its combined flow-cytometry and RT-PCR design provides a useful framework for separating age-dependent immune phenotypes from broad anti-inflammatory effects in neonatal sepsis research.

• Standardized Whole-Blood Stimulation and Immunometabolism

  2026-08-23

  Zhao and colleagues present a standardized ex vivo whole-blood protocol that combines defined immune stimulation with targeted metabolic intervention and cytokine measurement. Its main contribution is a reproducible framework for comparing donor immune responses while retaining the cellular and plasma context that is lost in many reductionist assays.

• BHA in Translational Oxidative Stress Research

  2026-08-22

  Butylated hydroxyanisole (BHA) is more than a routine antioxidant additive: it is a controllable redox perturbation tool for oxidative stress research, reactive oxygen species (ROS) detection, apoptosis interpretation, and translational assay design. This article connects BHA’s radical-scavenging chemistry with practical validation strategies and lessons from peptide drug-development research.

• Phosphatase Inhibitor Cocktail 1: Workflow Guide

  2026-08-21

  Phosphatase Inhibitor Cocktail 1 is a 100X DMSO-based alkaline phosphatase inhibitor blend for protein phosphorylation preservation during sample preparation. Its use can help maintain phosphorylation-dependent readouts for phosphoproteomic analysis, Western blotting, immunoprecipitation, and related biochemical assays.

448 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page